BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

573 related articles for article (PubMed ID: 28362430)

  • 1. CYLD, A20 and OTULIN deubiquitinases in NF-κB signaling and cell death: so similar, yet so different.
    Lork M; Verhelst K; Beyaert R
    Cell Death Differ; 2017 Jul; 24(7):1172-1183. PubMed ID: 28362430
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of deubiquitinases in human gingiva and cultured human gingival fibroblasts.
    Fu YW; Xu HZ
    BMC Oral Health; 2021 Jun; 21(1):290. PubMed ID: 34092220
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppression of LUBAC-mediated linear ubiquitination by a specific interaction between LUBAC and the deubiquitinases CYLD and OTULIN.
    Takiuchi T; Nakagawa T; Tamiya H; Fujita H; Sasaki Y; Saeki Y; Takeda H; Sawasaki T; Buchberger A; Kimura T; Iwai K
    Genes Cells; 2014 Mar; 19(3):254-72. PubMed ID: 24461064
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The E3 ubiquitin ligase MIB2 enhances inflammation by degrading the deubiquitinating enzyme CYLD.
    Uematsu A; Kido K; Takahashi H; Takahashi C; Yanagihara Y; Saeki N; Yoshida S; Maekawa M; Honda M; Kai T; Shimizu K; Higashiyama S; Imai Y; Tokunaga F; Sawasaki T
    J Biol Chem; 2019 Sep; 294(38):14135-14148. PubMed ID: 31366726
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reciprocal interplay between OTULIN-LUBAC determines genotoxic and inflammatory NF-κB signal responses.
    Li M; Li L; Asemota S; Kakhniashvili D; Narayanan R; Wang X; Liao FF
    Proc Natl Acad Sci U S A; 2022 Aug; 119(33):e2123097119. PubMed ID: 35939695
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deubiquitinases in the regulation of NF-κB signaling.
    Harhaj EW; Dixit VM
    Cell Res; 2011 Jan; 21(1):22-39. PubMed ID: 21119682
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Linear ubiquitination-mediated NF-κB regulation and its related disorders.
    Tokunaga F
    J Biochem; 2013 Oct; 154(4):313-23. PubMed ID: 23969028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subquinocin, a small molecule inhibitor of CYLD and USP-family deubiquitinating enzymes, promotes NF-κB signaling.
    Yamanaka S; Sato Y; Oikawa D; Goto E; Fukai S; Tokunaga F; Takahashi H; Sawasaki T
    Biochem Biophys Res Commun; 2020 Mar; 524(1):1-7. PubMed ID: 31898971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proinflammatory mediators alter expression of nuclear factor kappa B-regulating deubiquitinases in sinonasal epithelial cells.
    Li P; Wang Y; Turner JH
    Int Forum Allergy Rhinol; 2015 Jul; 5(7):583-9. PubMed ID: 25907801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression, biological activities and mechanisms of action of A20 (TNFAIP3).
    Verstrepen L; Verhelst K; van Loo G; Carpentier I; Ley SC; Beyaert R
    Biochem Pharmacol; 2010 Dec; 80(12):2009-20. PubMed ID: 20599425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biochemistry, Pathophysiology, and Regulation of Linear Ubiquitination: Intricate Regulation by Coordinated Functions of the Associated Ligase and Deubiquitinase.
    Fuseya Y; Iwai K
    Cells; 2021 Oct; 10(10):. PubMed ID: 34685685
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of NF-κB by deubiquitinases.
    Harhaj EW; Dixit VM
    Immunol Rev; 2012 Mar; 246(1):107-24. PubMed ID: 22435550
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LUBAC-Recruited CYLD and A20 Regulate Gene Activation and Cell Death by Exerting Opposing Effects on Linear Ubiquitin in Signaling Complexes.
    Draber P; Kupka S; Reichert M; Draberova H; Lafont E; de Miguel D; Spilgies L; Surinova S; Taraborrelli L; Hartwig T; Rieser E; Martino L; Rittinger K; Walczak H
    Cell Rep; 2015 Dec; 13(10):2258-72. PubMed ID: 26670046
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Linear ubiquitination in immunity.
    Shimizu Y; Taraborrelli L; Walczak H
    Immunol Rev; 2015 Jul; 266(1):190-207. PubMed ID: 26085216
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-proteolytic ubiquitination of OTULIN regulates NF-κB signaling pathway.
    Zhao M; Song K; Hao W; Wang L; Patil G; Li Q; Xu L; Hua F; Fu B; Schwamborn JC; Dorf ME; Li S
    J Mol Cell Biol; 2020 Apr; 12(3):163-175. PubMed ID: 31504727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular basis for the unique deubiquitinating activity of the NF-kappaB inhibitor A20.
    Lin SC; Chung JY; Lamothe B; Rajashankar K; Lu M; Lo YC; Lam AY; Darnay BG; Wu H
    J Mol Biol; 2008 Feb; 376(2):526-40. PubMed ID: 18164316
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Formation and removal of poly-ubiquitin chains in the regulation of tumor necrosis factor-induced gene activation and cell death.
    Kupka S; Reichert M; Draber P; Walczak H
    FEBS J; 2016 Jul; 283(14):2626-39. PubMed ID: 26749412
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SPATA2 promotes CYLD activity and regulates TNF-induced NF-κB signaling and cell death.
    Schlicher L; Wissler M; Preiss F; Brauns-Schubert P; Jakob C; Dumit V; Borner C; Dengjel J; Maurer U
    EMBO Rep; 2016 Oct; 17(10):1485-1497. PubMed ID: 27458237
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CYLD Limits Lys63- and Met1-Linked Ubiquitin at Receptor Complexes to Regulate Innate Immune Signaling.
    Hrdinka M; Fiil BK; Zucca M; Leske D; Bagola K; Yabal M; Elliott PR; Damgaard RB; Komander D; Jost PJ; Gyrd-Hansen M
    Cell Rep; 2016 Mar; 14(12):2846-58. PubMed ID: 26997266
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An Update on Autoinflammatory Diseases: Relopathies.
    Steiner A; Harapas CR; Masters SL; Davidson S
    Curr Rheumatol Rep; 2018 May; 20(7):39. PubMed ID: 29846841
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.